lu 135252 has been researched along with Chronic Disease in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boujedaini, H; Henry, JP; Mulder, P; Münter, K; Renet, S; Richard, V; Thuillez, C | 1 |
Arzt, M; Blumberg, FC; Lorenz, C; Pfeifer, M; Riegger, GA; Wolf, K | 1 |
Dietz, R; Enseleit, F; Hürlimann, D; Lüscher, TF; Mitrovic, V; Noll, G; Notter, T; Pacher, R; Philipp, S; Rousson, V; Ruschitzka, F; Schulze, MR; Willenbrock, R | 1 |
Piuhola, J; Ruskoaho, H; Szokodi, I | 1 |
Blumberg, FC; Holmer, SR; Kammerl, M; Krämer, BK; Pfeifer, M; Riegger, GA; Schweda, A; Schweda, F | 1 |
Blumberg, FC; Holmer, SR; Krämer, BK; Nabel, C; Pfeifer, M; Riegger, GA; Schweda, A; Schweda, F | 1 |
Bauersachs, J; Braun, C; Ertl, G; Fraccarollo, D; Kirchengast, M; Rohmeiss, P; Schilling, L; Widder, J | 1 |
Berger, R; Frey, B; Heher, S; Hülsmann, M; Neunteufl, T; Pacher, R; Stanek, B | 1 |
Cheng, TO | 1 |
Blumberg, FC; Lorenz, C; Pfeifer, M; Riegger, GA; Sandner, P; Wolf, K | 1 |
2 trial(s) available for lu 135252 and Chronic Disease
Article | Year |
---|---|
Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
Topics: Blood Pressure; Catecholamines; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Endothelin Receptor Antagonists; Europe; Female; Follow-Up Studies; Headache; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Hypotension; Male; Middle Aged; Phenylpropionates; Pulmonary Wedge Pressure; Pyrimidines; Receptor, Endothelin A; Shock, Cardiogenic; Treatment Outcome; Vascular Resistance; Ventricular Fibrillation | 2002 |
Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure.
Topics: Blood Flow Velocity; Brachial Artery; Chronic Disease; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Endothelium, Vascular; Female; Heart Failure; Heart Function Tests; Humans; Linear Models; Male; Middle Aged; Nitroglycerin; Phenylpropionates; Protein Precursors; Pyrimidines; Receptor, Endothelin A; Treatment Outcome; Vasodilation | 2001 |
8 other study(ies) available for lu 135252 and Chronic Disease
Article | Year |
---|---|
Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Coronary Vessels; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Endothelin Receptor Antagonists; Heart Failure; Hemodynamics; Ligation; Male; Myocardium; Peptidyl-Dipeptidase A; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; Stroke Volume; Survival Rate; Ventricular Function, Left; Ventricular Remodeling; Wakefulness | 2002 |
Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
Topics: Animals; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Hematocrit; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Lung; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylpropionates; Pressure; Pulmonary Artery; Pulmonary Circulation; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; RNA, Messenger; Systole; Ventricular Function, Right | 2003 |
Endothelin receptor blockade and exacerbation of heart failure.
Topics: Animals; Bosentan; Chronic Disease; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelins; Heart; Heart Failure; Humans; Myocardial Contraction; Phenylpropionates; Pyrimidines; Rats; Receptor, Endothelin A; Sulfonamides; Vascular Resistance; Water-Electrolyte Balance | 2003 |
Effects of chronic hypoxia on renal renin gene expression in rats.
Topics: Animals; Blood Pressure; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Gene Expression; Hypoxia; Kidney; Male; Molsidomine; Nitric Oxide Donors; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Renin; RNA, Messenger | 2000 |
Effects of chronic hypoxia on renal PDGF-A, PDGF-B, and VEGF gene expression in rats.
Topics: Animals; Chronic Disease; Endothelial Growth Factors; Endothelin Receptor Antagonists; Gene Expression Regulation; Hematocrit; Hemodynamics; Hypoxia; Kidney; Lymphokines; Male; Molsidomine; Nitric Oxide Donors; Phenylpropionates; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252.
Topics: Animals; Chronic Disease; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Kidney; Male; Myocardial Infarction; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; Renal Artery; Vasodilation | 2000 |
Endothelin receptor blockade in congestive heart failure.
Topics: Acute Disease; Antihypertensive Agents; Bosentan; Chronic Disease; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelin-1; Exercise Tolerance; Heart Failure; Hemodynamics; Humans; Phenylpropionates; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Treatment Outcome; Vasodilator Agents | 2001 |
Increased pulmonary prostacyclin synthesis in rats with chronic hypoxic pulmonary hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Chronic Disease; Cytochrome P-450 Enzyme System; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypoxia; Intramolecular Oxidoreductases; Male; Models, Animal; Molsidomine; Nitric Oxide Donors; Phenylpropionates; Pulmonary Artery; Pyrimidines; Random Allocation; Rats; Rats, Wistar; Receptor, Endothelin A; RNA, Messenger; Systole; Ventricular Pressure | 2002 |